[go: up one dir, main page]

AU2001292183A1 - Jet, an artificial promoter for gene expression - Google Patents

Jet, an artificial promoter for gene expression

Info

Publication number
AU2001292183A1
AU2001292183A1 AU2001292183A AU9218301A AU2001292183A1 AU 2001292183 A1 AU2001292183 A1 AU 2001292183A1 AU 2001292183 A AU2001292183 A AU 2001292183A AU 9218301 A AU9218301 A AU 9218301A AU 2001292183 A1 AU2001292183 A1 AU 2001292183A1
Authority
AU
Australia
Prior art keywords
jet
gene expression
artificial promoter
promoter
artificial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292183A
Inventor
Jens Tornoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NsGene AS
Original Assignee
NsGene AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NsGene AS filed Critical NsGene AS
Publication of AU2001292183A1 publication Critical patent/AU2001292183A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001292183A 2000-08-09 2001-08-09 Jet, an artificial promoter for gene expression Abandoned AU2001292183A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22408700P 2000-08-09 2000-08-09
US60/224,087 2000-08-09
US09/924,346 US6555674B2 (en) 2000-08-09 2001-08-08 JeT promoter
US09/924,346 2001-08-08
PCT/IB2001/001890 WO2002012514A2 (en) 2000-08-09 2001-08-09 Jet, an artificial promoter for gene expression

Publications (1)

Publication Number Publication Date
AU2001292183A1 true AU2001292183A1 (en) 2002-02-18

Family

ID=26918406

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292183A Abandoned AU2001292183A1 (en) 2000-08-09 2001-08-09 Jet, an artificial promoter for gene expression

Country Status (3)

Country Link
US (1) US6555674B2 (en)
AU (1) AU2001292183A1 (en)
WO (1) WO2002012514A2 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1677833T3 (en) 2003-10-20 2010-05-17 Nsgene As Virus vector for use in in vivo gene therapy of Parkinson's disease
AU2005229434B2 (en) 2004-03-30 2010-09-30 Nsgene A/S Therapeutic use of a growth factor, NsG33
WO2006013462A2 (en) * 2004-07-30 2006-02-09 Nsgene A/S Growth factors nsg28, nsg30, and nsg32
EP2271358B1 (en) 2008-03-25 2018-11-21 Amarantus Therapeutics, Inc. use of mesencephalic astrocyte-derived neurotrophic factor for treating Parkinson's disease
CA2750027C (en) 2009-01-23 2020-11-10 Nsgene A/S Improved cell lines and their use in encapsulated cell biodelivery
EP2389191A2 (en) 2009-01-23 2011-11-30 NsGene A/S Expression of neuropeptides in mammalian cells
EP2311961A1 (en) * 2009-10-15 2011-04-20 DKFZ Deutsches Krebsforschungszentrum Model-guided random assembly PCR for the synthesis of eukaryotic promoters
AU2011307488B2 (en) 2010-10-01 2015-08-20 Hoba Therapeutics Aps Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
WO2012094511A2 (en) 2011-01-05 2012-07-12 Rhode Island Hospital Compositions and methods for the treatment of orthopedic disease or injury
WO2016118902A1 (en) 2015-01-22 2016-07-28 Brown University Minimally-invasive and activity-dependent control of excitable cells
US10016514B2 (en) * 2015-05-15 2018-07-10 New Hope Research Foundation Polynucleotides, vectors and methods for insertion and expression of transgenes
EP4108255A1 (en) 2015-10-05 2022-12-28 Precision Biosciences, Inc. Genetically-modified cells comprising a modified human t cell receptor alpha constant region gene
AU2016333886B2 (en) 2015-10-05 2020-10-08 Precision Biosciences, Inc. Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
AU2017258304B2 (en) 2016-04-27 2019-07-04 University Of Puerto Rico 1,5-disubstituted 1,2,3-triazoles are inhibitors of Rac/Cdc42 GTPases
WO2017192741A1 (en) 2016-05-03 2017-11-09 Precision Biosciences, Inc. Engineered nucleases useful for treatment of hemophilia a
JP6887492B6 (en) 2016-10-04 2021-07-14 プレシジョン バイオサイエンシズ，インク． Co-stimulation domain for use in genetically modified cells
KR20230010826A (en) 2016-10-14 2023-01-19 프리시젼 바이오사이언시스 인코포레이티드 Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome
WO2018073393A2 (en) 2016-10-19 2018-04-26 Cellectis Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
AU2018254576B2 (en) 2017-04-21 2022-12-22 Precision Biosciences, Inc. Engineered meganucleases specific for recognition sequences in the PCSK9 gene
WO2018208837A1 (en) 2017-05-08 2018-11-15 Precision Biosciences, Inc. Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
AU2018292526A1 (en) 2017-06-30 2020-01-16 Precision Biosciences, Inc. Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
WO2019070856A1 (en) 2017-10-03 2019-04-11 Precision Biosciences, Inc. Modified epidermal growth factor receptor peptides for use in genetically-modified cells
US20200299658A1 (en) 2017-11-01 2020-09-24 Precision Biosciences, Inc. Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
US11142750B2 (en) 2018-04-12 2021-10-12 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
WO2019200122A1 (en) 2018-04-12 2019-10-17 Precision Biosciences, Inc. Optimized engineered nucleases having specificity for the human t cell receptor alpha constant region gene
EP3898661A1 (en) 2018-12-21 2021-10-27 Precision BioSciences, Inc. Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria
SG11202109972QA (en) 2019-03-11 2021-10-28 Sorrento Therapeutics Inc Improved process for integration of dna constructs using rna-guided endonucleases
CN116200342A (en) 2019-04-03 2023-06-02 精密生物科学公司 Genetically modified immune cells containing microRNA-adapted shRNAs (shRNAmiRs)
WO2020206231A1 (en) 2019-04-05 2020-10-08 Precision Biosciences, Inc. Methods of preparing populations of genetically-modified immune cells
EP4004216A1 (en) 2019-07-25 2022-06-01 Precision BioSciences, Inc. Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
WO2021035054A1 (en) 2019-08-20 2021-02-25 Precision Biosciences, Inc. Lymphodepletion dosing regimens for cellular immunotherapies
WO2021035170A1 (en) 2019-08-21 2021-02-25 Precision Biosciences, Inc. Compositions and methods for tcr reprogramming using fusion proteins
EP4069729B1 (en) 2019-12-06 2025-01-22 Precision BioSciences, Inc. Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
WO2021158915A1 (en) 2020-02-06 2021-08-12 Precision Biosciences, Inc. Recombinant adeno-associated virus compositions and methods for producing and using the same
GB202001930D0 (en) 2020-02-12 2020-03-25 Univ Sheffield Gene therapy
CA3175140A1 (en) 2020-03-12 2021-09-16 Immune-Onc Therapeutics, Inc. Novel anti-lilrb4 antibodies and derivative products
WO2021231259A1 (en) 2020-05-11 2021-11-18 Precision Biosciences, Inc. Self-limiting viral vectors encoding nucleases
EP4150068A1 (en) 2020-05-12 2023-03-22 Precision BioSciences, Inc. Treatment of retinitis pigmentosa using improved engineered meganucleases
EP4172208A2 (en) 2020-06-26 2023-05-03 Sorrento Therapeutics, Inc. Oncolytic herpes simplex viruses (hsv) expressing immunomodulatory fusion proteins
CA3172292A1 (en) 2020-08-21 2022-02-24 Cassandra GORSUCH Engineered meganucleases having specificity for a recognition sequence in the transthyretin gene
US20230365995A1 (en) 2020-10-07 2023-11-16 Precision Biosciences, Inc. Lipid nanoparticle compositions
EP4244342A1 (en) 2020-11-12 2023-09-20 Precision BioSciences, Inc. Engineered meganucleases having specificity for recognition sequences in the dystrophin gene
EP4274889A1 (en) 2021-01-08 2023-11-15 Precision BioSciences, Inc. Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene
US20250127811A1 (en) 2021-01-28 2025-04-24 Precision Biosciences, Inc. Modulation of tgf beta signaling in genetically-modified eukaryotic cells
MX2023012484A (en) 2021-04-22 2024-02-15 Prec Biosciences Inc Engineered meganucleases that target human mitochondrial genomes.
CA3173051A1 (en) 2021-04-22 2022-10-22 Precision Biosciences, Inc. Engineered meganucleases that target human mitochondrial genomes
CA3217602A1 (en) 2021-05-06 2022-11-10 Kenneth Petersen Prevention and treatment of chemotherapy-induced neuropathic pain
EP4419111A1 (en) 2021-10-19 2024-08-28 Precision Biosciences, Inc. Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
EP4419660A2 (en) 2021-10-19 2024-08-28 Precision BioSciences, Inc. Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
WO2023081767A1 (en) 2021-11-05 2023-05-11 Precision Biosciences, Inc. Methods for immunotherapy
JP2024546758A (en) 2021-12-10 2024-12-26 ホバ セラピューティクス エーピーエス Treating nociceptive pain
WO2023126458A1 (en) 2021-12-28 2023-07-06 Mnemo Therapeutics Immune cells with inactivated suv39h1 and modified tcr
CA3246480A1 (en) 2022-01-07 2023-07-13 Prec Biosciences Inc Optimized polynucleotides for protein expression
WO2024062138A1 (en) 2022-09-23 2024-03-28 Mnemo Therapeutics Immune cells comprising a modified suv39h1 gene
WO2024148167A1 (en) 2023-01-05 2024-07-11 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for the human t cell receptor alpha constant region gene
TW202507006A (en) 2023-04-12 2025-02-16 美商生命編輯治療學公司 Compositions and methods for the treatment of huntington's disease by editing the mutant huntingtin gene
WO2025101946A1 (en) 2023-11-08 2025-05-15 Precision Biosciences, Inc. Polypeptide linkers for use in engineered meganucleases
WO2025233894A1 (en) 2024-05-09 2025-11-13 University Of Miami Engineered meganucleases that target human mitochondrial genomes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2034021A1 (en) 1996-08-23 2009-03-11 Peter Ruhdal Jensen Artificial promoter libraries for selected organisms and promoters derived from such libraries
WO1998032869A1 (en) 1997-01-29 1998-07-30 Neurosearch A/S Expression vectors and methods for in vivo expression of therapeutic polypeptides

Also Published As

Publication number Publication date
WO2002012514A3 (en) 2002-08-08
US6555674B2 (en) 2003-04-29
WO2002012514A2 (en) 2002-02-14
US20020098547A1 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
AU2001292183A1 (en) Jet, an artificial promoter for gene expression
AU2002236096A1 (en) Salmonella promoter for heterologous gene expression
AU2001280796A1 (en) Electrowetting-driven micropumping
AU3369900A (en) Gene silencing
AU2001296718A1 (en) Methods for monitoring multiple gene expression
AU2001241682A1 (en) Gene expression system based on chimeric receptors
AUPQ262599A0 (en) Gene expression
AU2001265096A1 (en) Short-root gene, promoter, and uses thereof
AU2001242625A1 (en) Gene sequence
AU2001277581A1 (en) Myocardium-specific promoter
AU2001264247A1 (en) GASC1 gene
AU2001272265A1 (en) Improved uniformity ink jet system
AU2001266740A1 (en) Promoters for regulated gene expression
AUPR160400A0 (en) Plant virus promoter
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2001252591A1 (en) Novel promoters and gene expression method by using the promoters
AUPQ749100A0 (en) New epilespy gene
AU7567101A (en) Gene expression system
AU3996699A (en) Soybean gene promoters
AU2002211615A1 (en) Genetic insulator for preventing influence by another gene promoter
AU7116700A (en) Thermus promoters for gene expression
AU5561599A (en) Dna promoter sequence for gene expression
AU2001231457A1 (en) Genetic locus for everninomicin biosynthesis
AU2002222935A1 (en) Polycomb gene zmfie2 from maize
AU4006500A (en) (scarecrow) gene, promoter and uses thereof